SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...

neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children (>15 kg) living with severe allergic reactions Alfresa ...

In September 2025, analysts highlighted that the FDA waived the advisory committee meeting for Aquestive Therapeutics’ New Drug Application for Anaphylm, a needle-free, orally delivered epinephrine ...

Older adults are at greater risk for severe anaphylaxis in a variety of settings but are less likely to receive epinephrine than younger adults, two recent studies have found. In the first study, ...

Axcelis Technologies, Inc. (NASDAQ:ACLS) is one of the 14 Small Publicly Traded Semiconductor Companies to Invest in Now. On September 8, Axcelis Technologies, Inc. (NASDAQ:ACLS) introduced its new ...

Fintel reports that on October 2, 2025, Benchmark upgraded their outlook for Axcelis Technologies (NasdaqGS:ACLS) from Hold to Buy. Analyst Price Forecast Suggests 6.08% Upside As of September 30, ...

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have been in the spotlight this week as the company announced a merger with Veeco Instruments Inc. (NASDAQ:VECO) in order to gain scale and ...

TIME Magazine announces its Top 300 Best Inventions of 2025 (one North Vancouver company recognized) Vancouver, BC, October ...